Social Media Influencers Often Spread Misleading Prescription Drug Claims, Study Warns

A recent JAMA Network Open review highlights a troubling trend: social media influencers are frequently spreading misleading information about prescription drugs, often embedding promotional content within personal narratives that followers perceive as authentic and trustworthy.

Researchers emphasize that existing regulatory oversight has failed to keep pace with the rapid evolution of social media marketing, leaving audiences vulnerable to misinformation that could lead to medication misuse or harmful drug interactions.

Study Findings: Influencers and Prescription Drug Misinformation

The review, published in JAMA Network Open, examined how social media influencers shape public perception of prescription medications. Key findings include:

• Influencers often promote prescription drugs despite having financial incentives or limited medical expertise.
• Personal narratives shared by influencers can obscure promotional intent, making misleading claims appear credible.
• Current disclosure requirements are outdated and insufficient for addressing the nuances of social media marketing.

Expert Insights: The Risks of ‘Patient Influencers’

Study author Raffael Heiss, PhD, professor at the Management Center Innsbruck (MCI), warns that influencers—particularly those who identify as “patient influencers”—can blur the line between genuine advice and advertising. Heiss stated:

“Influencers often share advice about prescription drugs despite having financial incentives or little medical expertise. Existing rules and disclosure requirements have not kept pace with social media.”

Heiss also noted that personal stories can make promotional content feel trustworthy and authentic, even when incomplete or misleading. Followers may emotionally connect with these narratives and fail to recognize the content as advertising.

Public Health Concerns: Misinformation and Medication Misuse

The review raises significant public health concerns, particularly when promotions come from healthcare professionals. Kanwar Kelley, MD, triple board-certified in otolaryngology, head and neck surgery, obesity medicine, and lifestyle medicine, and co-founder and CEO of Side Health in Orinda, CA, commented on the issue:

“Social media influencers promoting prescription medication are blurring the lines between sound clinical advice and trend following. In today’s social media, that content is nearly indistinguishable from professional advice and can skirt the skepticism that people apply to traditional prescription marketing.”

Kelley, who was not involved in the study, emphasized that while influencers—especially those who are patients themselves—can provide valuable support, their promotional content may encourage inappropriate use or prescribing of medications.

Heiss added: “In some cases, especially when influencers are patients themselves, they can provide valuable support and help people feel less alone. However, our review suggests that these ‘parasocial’ relationships can also make people less likely to recognize when they are being marketed to and more likely to see the advice as trustworthy.”

Call for Stronger Regulations and Disclosure Standards

The researchers urge regulatory bodies to update guidelines to address the unique challenges posed by social media influencers. They recommend:

• Stricter disclosure requirements for influencer partnerships with pharmaceutical companies.
• Clearer distinctions between personal narratives and promotional content.
• Enhanced oversight to ensure influencers promoting prescription drugs have appropriate medical expertise.